Could a child's doctor visit spark a parent's quit-smoking journey?

NCT ID NCT06582693

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether proactively connecting household smokers to quit-smoking resources through a child's pediatric care visit increases their use of evidence-based treatments and quit rates. Adult household members who smoke are offered options like nicotine replacement, varenicline, quitline support, or text-based programs, along with motivational counseling. The study compares this approach to usual care and also looks at factors that influence success.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Refer2Quit intervention: automatic connection to evidence-based tobacco treatments (varenicline, nicotine replacement therapy, quitline, smokefreeTXT) plus motivational counseling and text messaging
What this could lead to
If effective, this approach could help more household smokers quit, reducing secondhand smoke exposure for children and improving family health.
What could go wrong
The trial relies on self-reported quit rates and may not reach all smokers. Success depends on participant engagement, and results may not generalize beyond this pediatric network.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SECOND HAND TOBACCO SMOKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.